Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Highlighting the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine at ICRS 2022

This year the International Cartilage Regenerative & Joint Preservation Society (ICRS) hosted its 16th World Congress in Berlin, Germany, and SmartTRAK covered it. This was the Society’s first in-person meeting since October 2019, and without a doubt, a very exciting moment for ICRS, its members and all who attended the event. For four days, industry stakeholders from around the world converged in Berlin to learn and hear about the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine. In this article, SmartTRAK gives a recap of some of the main topics presented during the meeting.

Among the many fascinating topics covered in the complete article, which can be downloaded here, are:

• The Role of Extracellular Vesicles 
• Use of Minced Cartilage
• Autologous, Matrix-induced Chondrogenesis 
• Feasibility of Gene Therapy
• Other Therapies of Tomorrow

SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the expansion of its solutions portfolio focused on new market coverage for Wound Debridement and Injectables for spinal disc degeneration and osteoarthritis (OA) of the knee.

SmartTRAK is an Insights-as-a-Service platform that equips customers with real-time, accurate market, company and product insights from hundreds of carefully curated data sources. The solution includes rich content provided through a SaaS platform and includes daily updates, tools and dashboards along with direct access to market analysts and expert advisory services.

Wound Debridement, a newly covered segment offered on the SmartTRAK platform, is foundational to wound healing and the success of every advanced wound care product. According to Wound Care market expert and General Manager Gary Delhougne, “our new module will cover the full scope of the debridement market opportunity and will be beneficial to companies directly participating or contemplating entering into the debridement space.” The Wound Debridement module is now widely available to customers.

Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions discusses the Company’s recent digital app launch as well as current and future trends in the digital field in an interview with SmartTRAK at SAWC Fall 2022.

Digital healthcare plays an increasingly important role in healthcare today. In the face of global concerns related to epidemics and pandemics, high costs and the effects of staff shortages, digital health-related technology continues to grow in importance and evolve. A broad scope of stakeholders are involved in the digital health field, including patients, practitioners, application developers and medical device manufacturers and distributors.

To find out more about Essity and the Company’s initiatives around digital solutions in wound care, click the video below to listen to the interview in which Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions, discusses the Company’s recent digital app launch and what the current and future trends in the digital field (05.33 min) are. A link to download the complete interview transcript is also provided below.

We are pleased to announce that Sara Cooley has joined the team at SmartTRAK as Relationship Manager, Customer Success. Sara has 5+ years of experience in Account Management and Sales in the medical device industry with a concentration in Orthopedics, Neurosurgery, and ENT. Her prior roles were with Kairos Surgical, an Arthrex Distributor, and American Surgical Company.

Meet Sara Cooley:

What is your role with SmartTRAK? Relationship Manager, Customer Success.

What do you like about SmartTRAK? I love that Smarttrak is helping to create an innovative industry by giving companies the information they need to make smart, strategic decisions based on industry trends.

SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive advancement in the spine market, including the shift of fusion procedures to the ASC setting, a potential tipping point for the adoption of endoscopic spine care, and emerging innovations within the interbody space.

At the North American Spine Society (NASS) 2022 Annual Meeting in Chicago, SmartTRAK witnessed a revival in energy that has been absent in recent years due to COVID-19, healthcare disruption and industry M&A integration. Exhibitors had the opportunity to teach attendees about new technology in a multitude of ways – a new live surgical theater was proudly projected throughout the exhibit hall and most companies were equally inviting to conversations about macro technology developments. Though SmartTRAK has seen so much innovation in spine over the recent several years, which of these advancements will truly lead to improved patient care? SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive growth in the spine market over the coming two-to-five years. These include the shift of procedures from the hospital to outpatient and ambulatory surgery center (ASC) settings, increased adoption and adaptation within surgical approaches and the introduction of custom interbody implants, and many others.

Among the many topics covered in detail in this article are:

Observations and analysis from the 37th Annual North American Spine Society (NASS) Meeting held October 12-14 in Chicago, IL. 

SmartTRAK highlights the top news and themes at NASS 2022 affecting the markets for OrthoBio and Regenerative Medicine, including the Orthofix/SeaSpine  merger, the ongoing controversy surrounding BMP-2, new product launches, company growth strategies and the latest research and innovation in intradiscal therapies.

Among the many topics covered in detail in this article are:

• A Spine Merger That Will Significantly Impact The Orthobiologics Landscape
• BMP-2 Safety Profile Remains an Open Issue
• Incremental Product Improvement Across OrthoBio Categories
• Spine Strategic Portfolio Strategies
• Intradiscal Treatments Take Center Stage

Undoubtedly, the proposed business combination of Orthofix and SeaSpine announced immediately prior to NASS was the most impactful news emanating from the meeting. On a proforma basis, the combined company is expected to generate approximately ...

To download and read the complete "OrthoBio-Focused Themes Emerging from NASS 2022" article by James Petricek,  SmartTRAK's GM, OrthoBio and Regenerative Medicine, just click the button below.

SmartTRAK is pleased to announce that Linda Bernier has been named new Chief Growth Officer (CGO). Linda will oversee Sales, Customer Success and Marketing. She will be involved with projects ranging from customer retention and satisfaction, licensing new tools and data sources, new products and strategy, marketing and new messaging, among others. She comes with a depth of experience in the healthcare and SaaS world, having held CEO and Chief Marketing Officer positions during her career

"Linda has great leadership and interpersonal skills (positivity, woo and communication are among her top strengths), and she likes to put ideas into action and get things done (achiever and strategic also in her top 5). Above all, she brings the experience, knowledge and confidence we have needed to successfully make the pivot to becoming a SaaS company with our new SmartTRAK Enterprise offering." SmartTRAK CEO Sharon O'Reilly

Meet Linda Bernier, SmartTRAK's new Chief Growth Officer:

What is your role with SmartTRAK? As Chief Growth Officer, my main objectives are to execute our founder and CEO Sharon O’Reilly’s vision for SmartTRAK and to achieve the company’s full potential as the leading market insights solution for the MedTech industry. In my role, I’ll be working with the sales, marketing and customer success teams to execute key initiatives to profitably grow the company. These initiatives include increasing client engagement, continuing our stellar > 95% retention rate through voice of client, acquiring new clients, elevating the SmartTRAK brand and expanding SmartTRAK’s portfolio of products and services, including the potential entry into new markets.
 
What do you like about SmartTRAK? When I listen to customers, they consistently say SmartTRAK is their trusted source for